Novo Nordisk A/S – Finance Tailwind

Trump asks drugmakers to cut U.S. prices within 60 days

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

Stocks making the biggest moves premarket: NVO, WHR, SRPT

Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance

Germany’s SAP flags U.S. trade hit but says Japan deal gives ‘hope’

Weight loss drugs could help treat PCOS

It’s all about the guidance

Hims & Hers offers generic semaglutide as Novo Nordisk patent lapses

Novo Nordisk ends Wegovy deal with Hims & Hers

TSLA, NTRS, DASH, XOM and more